MCID: MLG081
MIFTS: 46

Malignant Teratoma

Categories: Cancer diseases

Aliases & Classifications for Malignant Teratoma

MalaCards integrated aliases for Malignant Teratoma:

Name: Malignant Teratoma 12 14
Primary Malignant Extragonadal Teratoma 12
Malignant Extragonadal Teratoma 12
Immature Extragonadal Teratoma 69
Teratoma, Malignant 69
Immature Teratoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5563
MeSH 41 D013724
NCIt 46 C4286 C8884
SNOMED-CT 64 189847002 19467007

Summaries for Malignant Teratoma

MalaCards based summary : Malignant Teratoma, also known as primary malignant extragonadal teratoma, is related to mature teratoma and teratoma. An important gene associated with Malignant Teratoma is AFP (Alpha Fetoprotein), and among its related pathways/superpathways are Direct p53 effectors and Ceramide signaling pathway. The drugs Vinblastine and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include testis, thyroid and bone, and related phenotypes are behavior/neurological and endocrine/exocrine gland

Related Diseases for Malignant Teratoma

Diseases in the Teratoma family:

Malignant Teratoma Adult Teratoma
Intermediate Malignant Teratoma

Diseases related to Malignant Teratoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 183)
# Related Disease Score Top Affiliating Genes
1 mature teratoma 29.5 AFP POU5F1
2 teratoma 29.4 AFP ENO2 NKX2-1 POU5F1 SYP
3 seminoma 29.4 AFP ENO2 POU5F1
4 intermediate malignant teratoma 12.0
5 immature teratoma of ovary 11.2
6 malignant gastric teratoma 10.9
7 kashin-beck disease 10.5 BAX BCL2
8 alk-negative anaplastic large cell lymphoma 10.4 BAX BCL2
9 focal cortical dysplasia, type ii 10.4 BAX BCL2
10 suppressor of tumorigenicity 3 10.4 BAX BCL2
11 gastric lymphoma 10.4 BAX BCL2
12 cartilage-hair hypoplasia 10.4 BAX BCL2
13 melanotic medulloblastoma 10.4 AFP ENO2
14 head injury 10.4 BCL2 ENO2
15 pancoast tumor 10.4 AFP ENO2
16 mature teratoma of the ovary 10.3 ENO2 TG
17 acute thyroiditis 10.3 ENO2 TG
18 cystadenofibroma 10.3 AFP TG
19 mediastinal cancer 10.3 AFP SYP
20 water-clear cell adenoma 10.3 SYP TG
21 seminal vesicle tumor 10.3 AFP SYP
22 pancreatoblastoma 10.3 AFP SYP
23 spinal canal and spinal cord meningioma 10.3 ENO2 TG
24 urinary bladder small cell neuroendocrine carcinoma 10.3 ENO2 SYP
25 ovarian endodermal sinus tumor 10.3 AFP SALL4
26 sinonasal undifferentiated carcinoma 10.3 ENO2 SYP
27 auditory system cancer 10.3 ENO2 SYP
28 cutaneous ganglioneuroma 10.3 ENO2 SYP
29 sensory organ benign neoplasm 10.3 ENO2 SYP
30 middle ear adenoma 10.3 ENO2 SYP
31 gallbladder small cell carcinoma 10.3 ENO2 SYP
32 pancreatic somatostatinoma 10.3 ENO2 SYP
33 extrahepatic bile duct adenocarcinoma 10.3 ENO2 SYP
34 papillary tumor of the pineal region 10.2 ENO2 SYP
35 orbital cancer 10.2 ENO2 SYP
36 ovarian carcinosarcoma 10.2 ENO2 SYP
37 pulmonary large cell neuroendocrine carcinoma 10.2 ENO2 SYP
38 central nervous system primitive neuroectodermal neoplasm 10.2 ENO2 SYP
39 cerebellum cancer 10.2 ENO2 SYP
40 subependymal glioma 10.2 ENO2 SYP
41 olfactory nerve neoplasm 10.2 ENO2 SYP
42 cerebral neuroblastoma 10.2 ENO2 SYP
43 cauda equina neoplasm 10.2 ENO2 SYP
44 extraosseous chondrosarcoma 10.2 ENO2 SYP
45 benign ependymoma 10.2 ENO2 SYP
46 astroblastoma 10.2 ENO2 SYP
47 cerebral ventricle cancer 10.2 ENO2 SYP
48 cerebrum cancer 10.2 ENO2 SYP
49 thyroiditis 10.2
50 pancreatic cystadenocarcinoma 10.2 AFP SYP

Graphical network of the top 20 diseases related to Malignant Teratoma:



Diseases related to Malignant Teratoma

Symptoms & Phenotypes for Malignant Teratoma

MGI Mouse Phenotypes related to Malignant Teratoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.86 POU5F1 SALL4 SYP AFP BAX BCL2
2 endocrine/exocrine gland MP:0005379 9.63 NKX2-1 POU5F1 TG AFP BAX BCL2
3 nervous system MP:0003631 9.56 POU5F1 SALL4 SYP TG BAX BCL2
4 reproductive system MP:0005389 9.1 POU5F1 SALL4 AFP BAX BCL2 NKX2-1

Drugs & Therapeutics for Malignant Teratoma

Drugs for Malignant Teratoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 90)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vinblastine Approved Phase 3 865-21-4 241903 13342
2
Paclitaxel Approved, Vet_approved Phase 3,Phase 2,Phase 1 33069-62-4 36314
3
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
4
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
5
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 38904 498142
6
Bleomycin Approved, Investigational Phase 3,Phase 2 11056-06-7 5360373
7
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
8
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
9
Oxaliplatin Approved, Investigational Phase 3 61825-94-3 43805 6857599 5310940 9887054
10
Lenograstim Approved, Investigational Phase 2, Phase 3,Phase 1 135968-09-1
11
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
12
Captopril Approved Phase 3 62571-86-2 44093
13
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
14
Ribavirin Approved Phase 3 36791-04-5 37542
15
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
16
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
17
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
18
Palivizumab Approved, Investigational Phase 3 188039-54-5
19
Caspofungin Approved Phase 3 162808-62-0, 179463-17-3 2826718 468682
20 Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
21 Alkylating Agents Phase 3,Phase 2,Phase 1
22 Albumin-Bound Paclitaxel Phase 3,Phase 2,Phase 1
23 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
24 Hormone Antagonists Phase 3,Phase 2,Phase 1
25 Hormones Phase 3,Phase 2,Phase 1
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
27 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
28 Etoposide phosphate Phase 3,Phase 2
29 Antimitotic Agents Phase 3,Phase 2,Phase 1
30 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
31 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
32 Hydroxyitraconazole Phase 3
33
protease inhibitors Phase 3
34 Steroid Synthesis Inhibitors Phase 3
35 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
36 Cytochrome P-450 CYP3A Inhibitors Phase 3
37 HIV Protease Inhibitors Phase 3
38 Cytochrome P-450 Enzyme Inhibitors Phase 3
39 Angiotensin-Converting Enzyme Inhibitors Phase 3
40 Echinocandins Phase 3
41 Antibodies, Monoclonal Phase 3,Phase 1
42 Anti-Infective Agents Phase 3,Phase 2
43 Antifungal Agents Phase 3
44 Immunoglobulins Phase 3,Phase 1
45 Antihypertensive Agents Phase 3
46 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
47 Antimetabolites Phase 3
48 Liposomal amphotericin B Phase 3
49 Antibodies Phase 3,Phase 1
50 Antiprotozoal Agents Phase 3

Interventional clinical trials:

(show all 31)

# Name Status NCT ID Phase Drugs
1 Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors Unknown status NCT00274950 Phase 3 carboplatin;cisplatin;etoposide;ifosfamide;vinblastine sulfate
2 Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Unknown status NCT00104676 Phase 3 cisplatin;etoposide;ifosfamide;oxaliplatin;paclitaxel
3 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
4 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
5 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
6 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
7 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
8 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
9 Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Recruiting NCT03067181 Phase 3 Bleomycin;Carboplatin;Cisplatin;Etoposide
10 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
11 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
12 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
13 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
14 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
15 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
16 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
17 Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors Completed NCT00301782 Phase 2 carboplatin;cisplatin;etoposide phosphate;vincristine sulfate
18 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
19 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
20 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
21 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
22 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
23 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
24 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Recruiting NCT01037790 Phase 2 PD-0332991
25 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
26 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1 ipilimumab;therapeutic allogeneic lymphocytes
27 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
28 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
29 Anterior Mediastinum Teratoma: A Case Report Completed NCT00836121
30 Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Completed NCT00060021
31 Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Completed NCT00049465

Search NIH Clinical Center for Malignant Teratoma

Genetic Tests for Malignant Teratoma

Anatomical Context for Malignant Teratoma

MalaCards organs/tissues related to Malignant Teratoma:

38
Testis, Thyroid, Bone, Bone Marrow, Ovary, Liver, Colon

Publications for Malignant Teratoma

Articles related to Malignant Teratoma:

(show top 50) (show all 154)
# Title Authors Year
1
Radiological-pathological correlation of malignant teratoma with liposarcomatous transformation: Proven by repeated transthoracic needle biopsy. ( 29106050 )
2018
2
Malignant teratoma in Klippel-Feil syndrome: a case report and review of the literature. ( 26438353 )
2015
3
Chemoresponsive liver hemangioma in a patient with metastatic malignant teratoma. ( 25168798 )
2014
4
Pathology in practice. Malignant teratoma of the left ovary of a mouse. ( 24984129 )
2014
5
Primary malignant teratoma of lung: report of a case and review of the literature. ( 22180529 )
2012
6
Unusual presentation of fetus-in-fetu mimicking malignant teratoma. ( 21922882 )
2011
7
[Inhibitory effect of matrine on proliferation of human ovary malignant teratoma cell line PA-1 in vitro]. ( 20929131 )
2010
8
Malignant teratoma of the thyroid in a pregnant woman. ( 20637432 )
2010
9
What is your diagnosis? Peritoneal fluid from a 1-year-old female German Shepherd dog. Malignant teratoma. ( 20561318 )
2010
10
Successful pregnancy after treatment for ovarian malignant teratoma with growing teratoma syndrome. ( 19152879 )
2009
11
Case report: malignant teratoma of the uterine corpus. ( 19538751 )
2009
12
Primary malignant teratoma of the thyroid in a child with nodal metastases. ( 19332924 )
2009
13
Cystic malignant teratoma with early recurrence after intraoperative spillage. ( 19022022 )
2008
14
Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report. ( 18472634 )
2008
15
Primary malignant teratoma with a primitive neuroectodermal tumor component in thyroid gland: a case report. ( 17596674 )
2007
16
Malignant teratoma vs. carcinoma with teratomatous elements, rather than metaplastic carcinoma. ( 17097879 )
2007
17
Malignant teratoma 32 years after treatment of germ cell tumor confined to testis. ( 16566989 )
2006
18
Malignant teratoma of the thyroid: case report. ( 17199442 )
2006
19
Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report. ( 15922442 )
2005
20
Case report: malignant teratoma of the sinonasal tract. ( 15368065 )
2005
21
Thyroid carcinoma arising from a sacrococcygeal mass: a malignant teratoma? ( 15307946 )
2004
22
Malignant teratoma of the thyroid: aggressive chemoradiation therapy is required after surgery. ( 12804109 )
2003
23
Malignant teratoma of the orbit: a clinicopathological study of a case. ( 14685907 )
2003
24
Malignant teratoma of the medulla oblongata in an adult male. ( 11810399 )
2001
25
Malignant teratoma of the thyroid with primitive neuroepithelial and mesenchymal sarcomatous components. ( 11598856 )
2001
26
Malignant teratoma of the thyroid: review of literature and report of a case. ( 10758996 )
2000
27
Malignant teratoma of the thyroid with predominantly neuroepithelial differentiation. Fine needle aspiration cytologic, histologic and immunocytochemical features of a case. ( 10833994 )
2000
28
Malignant teratoma of the lung. ( 10665772 )
1999
29
Theriogenology question of the month. Malignant teratoma of the ovary. ( 10101408 )
1999
30
Immature malignant teratoma of the thyroid gland. ( 9646244 )
1998
31
Primary cervical malignant teratoma with a rib metastasis in an adult: five-year survival after surgery and chemotherapy. A case report with a review of the literature. ( 9818077 )
1998
32
Primary malignant teratoma of the thyroid gland: report and discussion of two cases. ( 9744468 )
1998
33
Malignant teratoma of the testis presenting with bilateral inguinal lymphadenopathy and diagnosed by fine needle aspiration (FNA). ( 9134338 )
1997
34
Retroperitoneal surgery: its wider role in the management of malignant teratoma. ( 8777620 )
1996
35
Primary pulmonary malignant teratoma with yolk sac element associated with hematologic neoplasia. ( 8833994 )
1996
36
Case report: malignant teratoma in the thyroid gland. ( 8983598 )
1996
37
Malignant teratoma undifferentiated (MTU) metastasising solely as differentiated teratoma: implications for the aetiology of residual differentiated disease following successful chemotherapy. ( 8562181 )
1995
38
Retroperitoneal malignant teratoma. A case report. ( 8935151 )
1995
39
Malignant teratoma of the testicle: diagnosis suggested by preoperative ultrasonography. ( 7502125 )
1995
40
Mediastinal malignant teratoma and acute myeloid leukemia in a patient with Klinefelter's syndrome--comparison of DNA content in the two malignancies. ( 7946452 )
1994
41
Carcinoma in situ of the testis followed by an overt malignant teratoma of the testis within 12 months. ( 7980264 )
1994
42
Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. ( 7923163 )
1994
43
MRI detection of ruptured malignant teratoma in the third ventricle. ( 8492886 )
1993
44
Prenatal diagnosis of intracranial teratoma. Prolonged survival after resection of a malignant teratoma diagnosed prenatally by ultrasound: a case report and literature review. ( 8382936 )
1993
45
Malignant teratoma arising in a dysgenetic gonad. ( 7690731 )
1993
46
Resection of an intracardiac metastasis from malignant teratoma of the testis. ( 8267441 )
1993
47
Management of malignant teratoma: does referral to a specialist unit matter? ( 8096954 )
1993
48
Malignant teratoma of the lung with lymph node metastasis of the ectodermal compartment: a case report. ( 8318068 )
1993
49
Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. ( 1279211 )
1992
50
True histiocytic malignancy associated with a malignant teratoma in a patient with 46XY gonadal dysgenesis. ( 1346359 )
1992

Variations for Malignant Teratoma

Expression for Malignant Teratoma

Search GEO for disease gene expression data for Malignant Teratoma.

Pathways for Malignant Teratoma

GO Terms for Malignant Teratoma

Cellular components related to Malignant Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 pore complex GO:0046930 8.62 BAX BCL2

Biological processes related to Malignant Teratoma according to GeneCards Suite gene sharing:

(show all 21)
# Name GO ID Score Top Affiliating Genes
1 ovarian follicle development GO:0001541 9.6 BAX BCL2
2 neuron apoptotic process GO:0051402 9.59 BAX BCL2
3 positive regulation of intrinsic apoptotic signaling pathway GO:2001244 9.58 BAX BCL2
4 response to gamma radiation GO:0010332 9.58 BAX BCL2
5 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.57 BAX BCL2
6 intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059 9.56 BAX BCL2
7 regulation of mitochondrial membrane potential GO:0051881 9.55 BAX BCL2
8 extrinsic apoptotic signaling pathway via death domain receptors GO:0008625 9.54 BAX BCL2
9 homeostasis of number of cells within a tissue GO:0048873 9.52 BAX BCL2
10 thyroid gland development GO:0030878 9.51 NKX2-1 TG
11 apoptotic mitochondrial changes GO:0008637 9.49 BAX BCL2
12 release of cytochrome c from mitochondria GO:0001836 9.48 BAX BCL2
13 B cell homeostasis GO:0001782 9.46 BAX BCL2
14 negative regulation of apoptotic signaling pathway GO:2001234 9.43 BAX BCL2
15 endoplasmic reticulum calcium ion homeostasis GO:0032469 9.4 BAX BCL2
16 regulation of protein heterodimerization activity GO:0043497 9.37 BAX BCL2
17 cellular response to organic substance GO:0071310 9.33 BAX BCL2 SYP
18 regulation of protein homodimerization activity GO:0043496 9.32 BAX BCL2
19 leukocyte homeostasis GO:0001776 9.26 BAX BCL2
20 regulation of nitrogen utilization GO:0006808 8.96 BAX BCL2
21 positive regulation of developmental pigmentation GO:0048087 8.62 BAX BCL2

Molecular functions related to Malignant Teratoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sequence-specific DNA binding GO:0043565 9.26 BCL2 NKX2-1 POU5F1 SALL4
2 channel activity GO:0015267 9.16 BAX BCL2
3 BH3 domain binding GO:0051434 8.62 BAX BCL2

Sources for Malignant Teratoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....